TIDMBSC

RNS Number : 4863H

British Smaller Companies VCT2 Plc

19 May 2014

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2014

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2014. The statement also includes relevant financial information between the end of the quarter and the date of this statement. This constitutes the Company's first interim management statement for the financial year ending 31 December 2014, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.com.

Performance

The total return at 31 March 2014, calculated by reference to the Net Asset Value (NAV) per ordinary share and the cumulative dividends paid per ordinary share, was 105.3 pence per ordinary share compared to 104.6 pence per ordinary share at 31 December 2013. Cumulative dividends represent 39.0 pence per ordinary share (31 December 2013: 39.0 pence per ordinary share).

The unaudited NAV per ordinary share as at 31 March 2014 was 66.3 pence (31 December 2013: 65.6 pence per ordinary share) representing an increase of 0.7 pence per ordinary share. The increase in NAV per ordinary share is principally due to the net upward movement, in both the AIM quoted and unquoted portfolio valuations.

The number of ordinary shares in issue at 31 March 2014 was 57,923,961 (31 December 2013: 46,443,563). In addition, at 31 March 2014, the Company held 1,777,722 ordinary shares in treasury (31 December 2013: 1,777,722).

Share Issues

During the period the Company has issued 11,480,398 ordinary shares between 68.00 to 71.19 pence per share, pursuant to the Company's joint offer for Subscription with British Smaller Companies VCT plc.

Net assets at 31 March 2014 comprised the following:

 
                                        % of net 
                               GBP000     assets 
 
 Unquoted investments at 
  fair value                   15,084      39.29 
 Quoted investments at 
  bid price                     2,575       6.71 
 Gilt investments                 890       2.31 
                              -------  --------- 
 Total investments             18,549      48.31 
                              -------  --------- 
 
 Cash and cash equivalents     15,349      39.98 
 Cash on fixed term deposit     4,500      11.72 
 Other net current assets         (4)     (0.01) 
                              -------  --------- 
 Net assets                    38,394     100.00 
                              =======  ========= 
 

The investment portfolio at 31 March 2014 was comprised as follows:

 
                                             Valuation 
                                                as a % 
                                 Valuation      of net 
                                    GBP000      assets 
 DisplayPlan Holdings Limited        2,075        5.40 
 Gill Marine Holdings Limited        1,870        4.87 
 Mangar Health Limited               1,640        4.27 
 Seven Technologies Holdings 
  Limited                            1,628        4.24 
 GTK (UK) Limited                    1,113        2.90 
 Immunobiology Limited                 987        2.57 
 Leengate Holdings Limited             934        2.43 
 Deep-Secure Ltd                       875        2.28 
 Callstream Group Limited              751        1.96 
 Pressure Technologies plc             682        1.78 
                                ----------  ---------- 
                                    12,555       32.70 
 
 Other investments                   5,104       13.29 
 Gilt investments                      890        2.32 
                                ----------  ---------- 
 Total investments                  18,549       48.31 
                                ==========  ========== 
 

During the three months ended 31 March 2014 the Company made two investments totalling GBP1.70 million. These comprised one new investment of GBP1.64 million into Mangar Health Limited, a world leader in inflatable lifting, handling and bathing equipment for the elderly, disabled and emergency services markets, and GBP0.06 million of follow- on investment into EKF Diagnostics plc.

In the 3 months to 31 March 2014 cash proceeds of GBP0.31 million were received relating to the repayment of capital from the Company's loan portfolio, including GBP0.05 million of redemption premiums following the early repayment of capital by DisplayPlan Holdings Limited. In addition the Company received GBP0.35 million from the sale of shares from its AIM quoted investment portfolio. In total these disposals generated a profit on the previous quarter's carrying value of GBP0.05 million.

Since the end of the quarter the Company has completed one further investment of GBP1.96 million into Intelligent Office Limited, a global provider and manufacturer of electronic solutions. In addition it has approved, but not yet completed, a further two investments totalling GBP1.55 million.

Portfolio Performance

Over the 3 months to 31 March 2014 the portfolio saw an overall increase in unrealised valuations of GBP0.30 million. This comprised an increase in the value of a number of portfolio companies following strong trading results including Pressure Technologies plc (up GBP0.25 million), DisplayPlan Holdings Limited (up GBP0.16 million), and Callstream Group Limited (up GBP0.11 million) together with resilient performances across much of the Company's remaining unquoted and AIM portfolio.

The Board continues to follow a policy of maintaining a diversified portfolio: as at 31 March 2014 there was only one investment representing more than 5 per cent each of the NAV of the Company.

Outlook

The Board believes that the current economic climate continues to create investment opportunities in the short to medium term in well managed UK businesses that need capital to expand. Following the increase in the investment limit applying to venture capital trusts to GBP5 million per investment in any one year there has been an increase in the number of investment opportunities presented to the Company. Since the period end the Company has completed and approved investments of GBP3.51 million..

19 May 2014

For further information please contact:

   David Hall                YFM Private Equity Limited                            Tel:  0113 294 5039 

Matt Thomas N+1 Singer Tel: 0207 496 3000

This information is provided by RNS

The company news service from the London Stock Exchange

END

IMSLLFLVEVIALIS

British Smaller Companie... (LSE:BSC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more British Smaller Companie... Charts.
British Smaller Companie... (LSE:BSC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more British Smaller Companie... Charts.